Planned cesarean delivery for very preterm twins is not associated with better survival to discharge without severe neonatal morbidity than planned vaginal delivery. The Green Journal #Preterm #TwinPregnancy #NeonatalMorbidity #JUMODA journals.lww.com/greenjournal/F…

Premiers résultats de l’essai BETADOSE sur une réduction de dose de 50 % du traitement anténatal par la bétaméthasone donné pour prévenir les complications de la prématurité : aphp.fr/contenu/premie… Hôpital Robert-Debré AP-HP | Inserm | Université Paris Cité

Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial. ⁦The Lancet⁩ thelancet.com/journals/lance…

Publication PASST trial GROG Alternative to intensive management of the active phase of the second stage of labor: a multicenter randomized trial among nulliparous women with an epidural ajog.org/article/S0002-…

Alternative to intensive management of the active phase of the second stage of labor: a multicenter randomized trial (PASST trial) among nulliparous women with an epidural - A, Intervention (moderate pushing) group. B, Control (intensive pushing) group. ow.ly/uVm350KZAey

📣 🚨 Le rapport de l’Enquête Nationale Périnatale 2021 est sorti aujourd’hui #ENP #perinatalite #grossesse #accouchement #naissances Le rapport complet est disponible sur le site enp.inserm.fr

In #TwinPregnancies, the risk of severe #PostPartumHemorrhage increases from 2% for sum of twins' birthweights below 3000 grams to 9% for sum exceeding 6500g (i.e. 35% risk increase for +500g in sum of birthweigths) #JUMODA The Green Journal GROG journals.lww.com/greenjournal/A…

New article from the TRAAP2 Study Group : « Surgeons’ gender was not associated with maternal morbidity after a cesarean delivery ». #TRAAP2 ja.ma/3kC9Ta5 CHU de Bordeaux EPOPé GROG JAMA Surgery JAMA Network

Discontinuation of #oxytocin during the active first stage of #labor, the French RCT STOPOXY which included almost 2500 patients (1192 vs 1175): no difference in neonatal morbidity, mode of delivery, indications for C/S. #SMFM2023 👏 Aude

Arrêt de l'#oxytocine pendant la phase active du 1er stade du travail, l’essai randomisé français STOPOXY avec près de 2500 patientes incluses (1192 vs 1175) : pas de différence de morbidité néonatale, du mode d'accouchement, des indications de césarienne #SMFM2023 👏 Aude

Some of the GROG study group (Groupe de Recherche en Obstétrique et Gynécologie) members at the #SMFM23 meeting to proudly represent French research in obstetrics!

Several members of the GROG study group are present at the 6th European Congress on Intrapartum Care to present their work #ECIC2023 #Belgrade 👏

Our correspondence in The Lancet about FRENCH-ARRIVE after serious, evidence-free, and false accusation of unethical research. With the support of Ben W Mol and colleagues for the need for appropriate language in the debate on medicalisation of pregnancy.

Pluriannual meeting of the GROG Study Group in Paris. Great research projects in perspective. #Obstetrics #Team #Research

Assistance Publique – Hôpitaux de Paris (AP-HP) Inserm Université Paris Cité Fière de cet essai et de cette belle publication avec Aude et le GROG

The early use of intrauterine balloon tamponade did not reduce the incidence of severe postpartum hemorrhage compared with its use after the failure of second-line uterotonic treatment and before recourse to invasive procedures AJOG pubmed.ncbi.nlm.nih.gov/37209893/

Among participants receiving oxytocin in early labour, discontinuing oxytocin when the active phase is reached does not clinically or statistically significantly reduce neonatal morbidity compared with continuous oxytocin. The Lancet Camille Le Ray Aude pubmed.ncbi.nlm.nih.gov/37952548/

Migration sur Bluesky ---> grog-studygroup.bsky.social